When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   Recent steps suggest that options for colorectal cancer screening are continuing to expand. Why did the FDA approve the new colon cancer blood test? On July 29, 2024, ...

3. A new way to screen for colon cancer may be on the horizon ...

   www.aol.com/news/way-screen-colon-cancer-may...

   Colon cancer screening is generally recommended starting at age 45, but less than 60% of people who are eligible are up to date. “In an ideal world, everyone goes to get a first colonoscopy at 45.

4. A new type of bacteria was found in 50% of colon cancers ...

   www.aol.com/news/type-bacteria-found-50-colon...

   Colon cancer is the second-leading cause of cancer deaths in the United States and is expected to kill more than 53,000 people in the nation in 2024, according to the American Cancer Society.

5. Colorectal cancer - Wikipedia

   en.wikipedia.org/wiki/Colorectal_cancer

   Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). [5] Signs and symptoms may include blood in the stool , a change in bowel movements , weight loss, abdominal pain and fatigue. [ 9 ]

6. Colonoscopy - Wikipedia

   en.wikipedia.org/wiki/Colonoscopy

   Treatment consists of intravenous fluids, antibiotics, and avoiding oral intake of food, water, etc. until symptoms improve. Risk factors include right colon polypectomy, large polyp size (>2 cm), non-polypoid lesions (laterally spreading lesions), and hypertension. [50] Although rare, infections of the colon are a potential colonoscopy risk.

7. Aflibercept - Wikipedia

   en.wikipedia.org/wiki/Aflibercept

   Common adverse effects of the eye formulation include conjunctival hemorrhage, eye pain, cataract, vitreous detachment, floaters, and ocular hypertension. [14]Aflibercept (Zaltrap) has adverse effects typical of anti-cancer drugs, such as reduced blood cell count (leukopenia, neutropenia, thrombocytopenia), gastrointestinal disorders like diarrhea and abdominal pain, and fatigue.